A Finnish study (Eerola et al, 2001) of 107 breast or ovarian cancer families reported a five-fold increase in the RR of prostate cancer among men carrying protein-truncating BRCA2 mutations (RR=4.9, 95%CI 1.8–11.0). The gene discussed is BRCA2; the disease is ovarian cancer.